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Abstract
Background: Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) are serious health concerns,
especially in Western populations. Antibiotic exposure and high-fat diet (HFD) are important and modifiable factors
that may contribute to these diseases.
Methods: To investigate the relationship of antibiotic exposure with microbiome perturbations in a murine model
of growth promotion, C57BL/6 mice received lifelong sub-therapeutic antibiotic treatment (STAT), or not (control),
and were fed HFD starting at 13 weeks. To characterize microbiota changes caused by STAT, the V4 region of the
16S rRNA gene was examined from collected fecal samples and analyzed.
Results: In this model, which included HFD, STAT mice developed increased weight and fat mass compared
to controls. Although results in males and females were not identical, insulin resistance and NAFLD were
more severe in the STAT mice. Fecal microbiota from STAT mice were distinct from controls. Compared with
controls, STAT exposure led to early conserved diet-independent microbiota changes indicative of an immature microbial
community. Key taxa were identified as STAT-specific and several were found to be predictive of disease. Inferred network
models showed topological shifts concurrent with growth promotion and suggest the presence of keystone species.
Conclusions: These studies form the basis for new models of type 2 diabetes and NAFLD that involve microbiome
perturbation.
Background
Obesity is currently a world-wide epidemic [1] and is
linked to metabolic diseases including type 2 diabetes
and non-alcoholic fatty liver disease [2]. Obesity heightens
the risk for the development of these disorders, yet the
relevant mechanisms are not fully understood [2]. How-
ever, the microbiota of the gut may be involved in the
pathogenesis of obesity, possibly through effects on energy
balance, nutrient absorption, inflammatory pathways, and
the gut-brain axis [3]; causal interactions among these
factors are generally undescribed.
For nearly 70 years, farmers have been giving low
doses of antibiotics to livestock to promote their growth
[4, 5]. Human and rodent studies have established a
strong association between a perturbed microbiome and
the development of obesity and related metabolic dys-
function [6–10]. Our prior studies have established
models of antibiotic exposures in mice that have led to
accelerated growth and to perturbation of host meta-
bolic and inflammatory responses [11–13]. In each of
these studies, antibiotic exposure substantially altered
the gut microbiota. In a pivotal experiment, colonizing
germ-free recipient mice with antibiotic-altered commu-
nities of intestinal microbes was sufficient to transfer the
adiposity [12]. This established a causal role for what
we have termed “microbe-induced obesity” [3]. Adding
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a high calorie, high-fat diet (HFD) exacerbated the
effects of the altered microbiota on both adiposity and
hepatic gene expression [11, 12].
In this study, we exposed mice to long-term low dose
penicillin (STAT) or not (control), and then changed
their diet to HFD to enhance the adiposity phenotype.
By studying metabolic and hepatic functions in mature
mice (aged >30 weeks), we found that this regimen pro-
moted insulin resistance and hepatic steatosis. Here, we
sought to understand the relationship of those pheno-
types with metrics related to the gut microbiome. Defin-
ing statistical associations between members of the gut
microbial community and host phenotypic development
in response to perturbation is an essential challenge for
inferring mechanism from systems-level data. We describe
a novel computational pipeline for estimating the sig-
nificance of community change upon treatment and for
estimating the significance of individual taxa differences
between STAT and control.
Methods
Animals and exposures
C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME,
USA), were allowed to acclimate to our animal facility
for 1 week prior to breeding. After 2 weeks, breeding
pairs were separated and pregnant dams randomized into
control or sub-therapeutic antibiotic treatment (STAT)
groups. Penicillin G (6.8 mg/L; STAT) or not (control)
was added to drinking water dams at ~ day 14 of gestation,
as described [12 13]. Pups were weaned at day of life
(dol) 28 and continued receiving the same treatment
(STAT or control) throughout the 32-week study. All
mice had ad libitum access to water and chow (Purina
Mills International Diet #5001, 4.07 kcal/g, with 13.5 % kcal
from fat). At week 13, all mice were switched onto HFD
(4.73 kcal/g, with 45 % kcal from fat; Rodent Diet D12451,
Research Diets, New Brunswick NJ, USA). Mice were
weighed and fecal pellets were collected regularly through-
out the experiment (Additional file 1: Figure S1).
Body composition
Body composition was measured using dual energy X-ray
absorptiometry (DEXA) with a Lunar PIXImus II mouse
densitometer (GE Medical Systems, Waukesha, WI, usa)
at weeks 4, 8, 12, 20, 24, and 28 with anesthesia by isoflur-
ane inhalation, as described [13].
Food intake and caloric excretion
At week 21 while receiving HFD, 12 mice (control and
STAT males and females; n = 3/group) were individually
housed in metabolic cages (Tecniplast, Buguggiate, Italy).
The mice were allowed 2 days to acclimate, and then were
observed and studied for the next 3 days, with daily
weighing of the mice, their food, water, feces, and urine.
Caloric intake was calculated as food consumed (g) multi-
plied by 4.73 kcal/g (Research Diets). Bomb calorimetry
was used to quantify calories present in feces. For each
mouse, the entire fecal output/24-h period during the
3-day observation period was homogenized, and di-
vided into duplicate (10–20 mg) aliquots, dried over-
night at 55 °C with silica gel as a desiccant, and caloric
content of the dried aliquots measured in a bomb cal-
orimeter (Semimicro Calorimeter, Thermometer, and
Oxygen Bomb; Parr Instrument Company, Moline, IL,
USA), using benzoic acid as a standard; mean caloric
output was calculated, as described [13].
Glucose and insulin homeostasis
Intraperitoneal (IP) glucose tolerance tests (IPGTT) and
IP insulin tolerance tests (IPITT) were performed during
afternoons following 4 h of fasting. For the GTT, mice
were injected IP with 1 mg glucose/g body weight in
sterile water. Before (time 0), and after (15, 30, 60, and
120 min) the IP injection, blood glucose was measured
with an Abbott (Abbott Park, IL, USA) Freestyle Lite
glucometer. During the GTT, in seven of the 27 mice
tested (3/13 in STAT and 4/14 in control), blood glucose
levels between 15 and 60 min were >500 mg/dL. Since
this was above the detection limit, such mice were defined
as having levels of 500 mg/dL. For the ITT, 0.5 U/g body
weight of insulin (Humulin R, Eli Lilly, Indianapolis, IN,
USA) was injected IP, and glucose measured as above. In
the last hour of the test, 11 of the 27 mice became severely
hypoglycemic, unresponsive to noise and physical stimula-
tion. These mice were rescued with an IP glucose solution,
removed from further ITT measurements, and returned
to their cages with food for observation; rescued mice
were defined as having blood glucose levels of 20 mg/dL
for the next time point. Homeostatic model assessment of
insulin resistance (HOMA-IR) score was calculated by
((glucose mg/dL x insulin mU/L)/405), as described [14].
To determine a normal range for HOMA-IR values in
mice, strain/age/diet-matched paired glucose and insulin
data were obtained from the literature [15]; since a value
of 13.2 separated normal and elevated HOMA-IR scores,
we used this to define the upper limit for normal in our
study. For grouping purposes, mice were considered to be
insulin-resistant when they had ≥2 of the following cri-
teria: HOMA-IR >13.2, impaired glucose tolerance by
IPGTT, impaired insulin sensing by IPITT.
Statistical analysis
We fit a piecewise linear mixed regression model [16] to
the weight, fat, lean, GTT, and ITT data to compare the
group patterns of change over time during early, middle,
post-HFD, and later stages of the experiment. For the
weight data, we consider the model with common knots
at weeks 5, 13 (when HFD was started), and 22. With
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this model, we performed the group comparisons of
changing group trends over the periods: weeks 3–5,
weeks 5–13, weeks 13–22, and week 22–31. Cage infor-
mation was fitted as a random effect in the model to
take account for possible correlations among the mice in
the same cage. The MIXED procedures of SAS software
(version 9.2; SAS Institute Inc., Cary, NC, USA) were
used to perform the tests and calculate the estimates.
For fat, lean, GTT and ITT, the models are similar
except for using different knots. Both the STAT and
Control groups were each composed of five or more
cages, across two asynchronous cohorts, in two different
mouse facilities. The cage effects- as well as sex- are
implicitly accounted for in the multi-level PLS model
(see below) since we first subtract the variance between
the repeated measures made on the same subject. There-
fore, first order effects from factors related to within-
subject repeated measures (i.e. cage, sex, aging) are
removed. Mathematically, this is equivalent to a linear
mixed-effect model but the PLS approach extends to
multivariate responses and designs, which accounts for
colinearity within the dataset.
Hormone and cytokine measurements
Serum concentrations of insulin, C-peptide, leptin, ghrelin,
IL-6, and TNFα were measured using Multiplex Biomarker
Immunoassays for Luminex xMAP technology (Millipore,
Billerica, MA, USA; panel MMHMAG-44 k), with reading
by Luminex 200 analyzer, as described [13]. These mea-
surements were made using cardiac blood from sacrifice.
All mice were fasted for 4 h prior to sacrifice.
Lipid extraction and measurement
For lipid extraction, based on a modified Folch method
[17], ~100 mg of tissue in 500 μL of PBS was homoge-
nized using stainless steel beads for 1 min in a Powerlyzer
homogenizer. From each sample, 50 μL was removed for
protein analysis (BCA reagent, Thermo Scientific) and
1.5 mL of 2:1 chloroform:methanol added, the solution
vortex-mixed, then samples centrifuged for 10 min at
3000 rpm at 4 °C. The organic phase was collected and
dried under nitrogen gas. The dried lipid was dissolved in
500 μL of 2 % Triton-X 100 in chloroform, further dried,
and then dissolved in 100 μL of phosphate buffered saline
(PBS), pH 7.4. Triglyceride and total cholesterol were
measured using the Thermo Scientific (Waltham, MA,
USA) Infinity assays. Free fatty acids were measured using
the Wako NEFA kit (Wako Life Sciences, Richmond, VA,
USA). Lipid mass was normalized to protein mass.
Hepatic gene expression
Tissue was preserved in RNeasy at –80 °C post-sacrifice
and RNA was extracted using miRNeasy Mini Kit
(Qiagen), essentially as described [18]. In brief, samples
were converted into cDNA using SuperScript II Reverse
Transcriptase (Invitrogen), and expression determined by
real-time quantitative PCR (RT-qPCR), using SYBR Green
(Life Technologies) in combination on a 480 LightCycler
(Roche). Each well contained 18 uL MasterMix solution
(0.0 5uL of 10 uM forward/reverse primers, 10 uL SYBR
Green, and 7 uL molecular grade H2O). For absolute
quantitation, the plasmid standard curve was diluted by
tenfold in EB buffer. Primer sequences and annealing
temperatures were described [18, 19]. qPCR cycling was
optimized to each primer-set to ensure Efficiency >1.90
and Error Rate <0.02. Relative concentrations were calcu-
lated using the ΔΔCt method, as described [20], and
p values calculated using the non-parametric Mann–
Whitney U test.
Non-alcoholic fatty liver disease assessment
Liver sections were dissected and fixed in 10 % neutral
buffered formalin, then paraffin-embedded. Slides were
cut, stained with hematoxylin and eosin (H&E), and
Masson’s Trichrome, then scanned at 40× and 200×, and
scored for non-alcoholic fatty liver disease (NAFLD), as
described [21].
Microbial community analysis
Total genomic DNA was extracted from frozen fecal sam-
ples using the Powersoil DNA Extraction Kit (MoBio,
Carlsbad, CA, USA) in 96-well format and the 16S rRNA
gene was amplified with barcoded fusion primers, target-
ing the V4 region, as described [22]. Amplicon pools were
sequenced on the 2 × 150 bp Illumina MiSeq platform.
The QIIME pipeline [23] was used for quality filtering,
demultiplexing, taxonomic assignment, and calculating
diversity metrics, as described [12]. Sequencing depth,
paired-end joining efficiency, and other quality metrics
can be found in Additional file 2: Figure S2. We found no
significant differences between males and females in either
treatment group by clustering or UniFrac distances (data
not shown) or between cages (Additional file 3: Table S1,
Adonis test). Since there were no differences and stratifi-
cation reduces analytical power, the sexes were combined
for microbiome analyses. To make the data more inter-
pretable, we edited the OTUs according to their repre-
sentation amongst the samples. We arrived at 723
OTUs by discarding OTUs that were present in fewer
than 10 % of all fecal samples. This was an arbitrary
cutoff, used both to reduce the noise of amplicon
datasets and to avoid spurious associations when there
is a preponderance of zero counts. Linear discriminant
analysis effect size (LEfSe) [24] was used to detect sig-
nificant differences in relative abundance of microbial
taxa and predicted KEGG pathways between control
and STAT mice. Microbiota-by-age z-scores (MAZ)
were calculated as described [25], using the following
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formulae: Microbial maturity (MM) = predicted microbiota
age −median microbiota age of control mice of similar age.
MAZ=MM/S.D. of predicted microbiota age of control
mice of similar age.
Supervised classification of disease state
Random forests classification models were built for pre-
diction of disease outcomes (NAFLD/elevated HOMA-
IR development) as a function of microbial composition
and to predict age as a function of microbial compos-
ition, as described [11]. Each model was built by growing
1000 trees per forest and d/3 variables (operational
taxonomic units, OTUs) randomly sampled at each split,
where d is the total number of OTUs in each model.
Model error was calculated using a leave-one-out ap-
proach. To avoid bias from uneven sampling efforts, all
samples were randomly subsampled at 1000 OTU/sample
prior to analysis. Subsampling and analysis was performed
in ten independent trials, with results used to calculate
mean model error and OTU importance.
Sparse and compositionally-robust multilevel PLS
regression
We developed a novel framework to detect associations
between specific taxa in fecal microbiota communities
and longitudinally-measured host phenotypes. To over-
come the detection of statistically spurious associations,
we incorporated: (1) the compositionally robust centered
log-ratio (clr) transformation of OTU relative abundance
data; (2) variance decomposition for multi-level experi-
mental design; and (3) estimation of a sparse linear
model via sparse Partial Least Squares (sPLS) regression
for connecting high-dimensional and multi-collinear
features (OTUs, taxa) and responses (phenotype mea-
surements). We selected seven host phenotype measure-
ments of interest: Body Fat (Fat), Bone Mineral Content
(BMC), Lean Mass (Lean) and Dry Mass Index (DMI)
(all measured by DEXA), scale weight (Weight), next
closest time point of Weight (Weight + 1), and end-of-
life NAFLD scores. OTUs that appeared in fewer than
10 % of samples across the entire dataset were removed,
leaving a remaining 723 OTUs of interest across 308
samples. A single pseudo-count was added to the fecal
microbiota data, to correct for zero-counts, and then
center log-ratio transformed [26]. We then decomposed
the resulting OTU features and host response data into
the relevant “within-subject” components using the
two-factor (antibiotic group and diet switch) variance
decomposition, as described [27]. The within-subject
component captures experimental perturbation effects
by subtracting between-subject variances.
We then applied L1-penalized PLS regression to the
within-subject data [28–30] and fit a bi-linear model.
The number of latent components in the sPLS model is
fixed to seven (or to the number of non-zero singular
values in the cross-covariance matrix). Model sparsity is
controlled via the scalar parameter η that weights the in-
fluence of the L1 penalty. We used a two-stage approach
to find a sparse set of significant OTU-phenotype associ-
ations. In the first stage, we used stability approach to
regularization selection (StARS [31]); the StARS method
has been previously shown to be competitive for graph-
ical model problems of similar complexity and scale
[31]. We rebuilt the sPLS model over 50 random subsets
of the data over a range of values for η, calculating the
fraction of data subsets that included a given OTU in
the support (i.e. non-zero model coefficients) at each η.
We then computed a summary statistic of overall model
stability to select the most stable model that exceeds the
variability threshold (0.1 %) [31]. In the second stage, we
assessed the statistical significance of individual OTUs
in the model by computing empirical p values over 2000
bootstrapped PLS models (using the StARS-selected
support) p values computed for an empirical null model,
generated by randomly permuting the data. We used rou-
tines from the sPLS and caret libraries in R to developed a
custom package (which includes methods for the full pipe-
line and a similar approach for discriminant analysis [32])
called compPLS (software and supplemental methods are
available at http://github.com/zdk123/compPLS).
Clustering of sPLS scores
We clustered the 308 individual samples based on their
seven-dimensional sPLS scores using a finite Gaussian
mixture model. An EM algorithm was used to find the
optimal number of components, initialized with ag-
glomerative clustering. We used the maximal Bayesian
Information Criterion (BIC) to find optimal model type
(ellipsoidal, equal orientation mode) and number of
clusters (six clusters) (Additional file 4: Figure S3). All
clustering computation was done with the mclust pack-
age in R [33].
Estimation of microbial association networks
Each of the six clusters of individuals/experiments corre-
sponds to phenotypically similar samples. For each sample
set we learned microbial association networks using the
Sparse InversE Covariance estimation for Ecological ASso-
ciation Inference (SPIEC-EASI) framework [34]. Nodes in
each network correspond to OTUs and edges correspond
to direct signed interactions between OTUs given each
environment. We ran SPIEC-EASI in neighborhood selec-
tion mode and performed model selection via StARS
using a variability threshold of 0.05 %.
Analysis of microbial association networks
To assess the overall similarity of the six different associ-
ation networks we enumerated all induced subgraphs
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(graphlets) composed of up to four nodes in each
network and recorded, for each node, the frequency of
participation in each subgraph. Following [35] we can
use the Spearman correlation matrix among 11 non-
redundant subgraph frequencies (orbits) across all nodes
as a robust and size independent network summary
statistics. Pairwise distances between entire networks are
computed by using the Frobenius norm between the
correlation matrices (graphlet correlation distance [35]).
To achieve a low-dimensional description of network
similarities we embedded these distances in Euclidean
space using classical MDS.
We also assessed the robustness of the different mi-
crobial association networks to random and targeted
node removals (“attacks”) [36, 37] using natural con-
nectivity [38] as a general measure of graph stability.
Natural connectivity (a variant of the Estrada index of a
complex network [39]) is a graph-theoretic measure of
global network connectivity that has been shown to be
more reliable and sensitive than other stability metrics
(such as algebraic connectivity or size of largest compo-
nent) when evaluating attack robustness of complex
networks [38]. We measured how natural connectivity
of the microbial network changed when nodes and their
associated edges are sequentially removed from the
network. We considered three network attack scenar-
ios: (1) uniformly at random node removal; (2) node
removal based on betweenness centrality; and (3) node
removal based on node degree. Betweenness centrality
[40] measures a node’s centrality in a network by calcu-
lating the number of shortest paths from all nodes to
all others that pass through that particular node. Nodes
with high betweenness centrality generally correspond
to “bottlenecks” in the network, which play a crucial
role in the organization of biological networks [41].
Nodes with high node degree (i.e. number of neighbors)
represent “hubs” or keystone species in the network.
Sequential removal of nodes based on the ranking of
these scores thus represents targeted (worst-case) at-
tacks on network stability. For comparison, the random
node removal scenario (averaged over n = 50 repeti-
tions) assesses the baseline robustness of the network.
Results
Combining STAT with high-fat diet increases body weight
We first sought to confirm and extend our prior studies
of the effect of STAT on murine development [12, 13],
in both males and females (Fig. 1). Analysis of the
whole-life growth curves shows that STAT mice were
heavier than controls from the very first weights obtained
after weaning at week 4 (males only), with differences
continuing to the end of the experiment (Fig. 2a–c). Both
male and female STAT-exposed mice had increased body
weight over time compared to controls, with the major
differences occurring after HFD initiation at week 13
(Fig. 2a). After introduction of HFD at week 13, weight
gain of STAT mice was greater than in controls (males,
20.0 ± 2.5 g vs. 13.1 ± 3.7 g; p <0.001; females, 13.7 ± 5.8 g
vs. 5.1 ± 2.4 g; p <0.001), showing that the antibiotic
exposure potentiated the effects of the HFD. At 32 weeks,
both STAT males and females remained significantly
larger than controls (Fig. 2c). These studies confirm our
prior findings of enhanced growth of mice in the STAT
model [12, 13], with acceleration of the growth differences
in the presence of HFD.
STAT with a high-fat diet increases body fat
Beginning at weaning, body composition of all mice was
measured by DEXA. Although STAT mice tended to















Fig. 1 Study design. C57Bl/6 dams were bred, and then randomized to STAT and control groups. Resultant pups continued treatment and were
weighed and had fecal samples collected 2–3 times per week until sacrifice at 32 weeks. All mice were switched to a high-fat diet at week 13. A
second iteration of this design was performed to increase the number of pups in each group
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Fig. 2 (See legend on next page.)
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weight differences observed largely reflected fat mass
(Fig. 2f, g), which were enhanced by HFD in both sexes.
Measurements of bone composition (mineral density,
mineral content, and area) were not significantly differ-
ent in relation to sex, treatment, or diet throughout the
experiment (Additional file 1: Figure S1, Panels E, F, and
G respectively). Taken together, these data indicate that
STAT led to weight gain predominantly in fat mass,
beginning early in life, exacerbated by HFD, with little or
no effect on lean mass or on bone development, under
the conditions studied.
STAT does not markedly perturb host energy balance
To determine whether STAT was altering food intake or
energy harvest, 21-week-old mice were studied in meta-
bolic cages. For individually housed control and STAT
male and female mice, we measured food and water
intake and waste production for 5 days. Food intake in
STAT males was not different compared to controls, but
STAT females consumed fewer total calories daily than
control females (Additional file 1: Figure S1A). Fecal
calorie content (per gram) measured using bomb calorim-
etry did not vary by sex or exposure group (Additional file
1: Figure S1B). Neither net calories (Additional file 1:
Figure S1C; calories IN minus OUT), nor the proportion
of calories retained (Additional file 1: Figure S1D; IN
minus OUT/IN) was altered by STAT exposure. These
data provide evidence that STAT-related adiposity did not
result from either increased appetite or enhanced energy
harvest.
STAT affects glucose and insulin homeostasis
Based on the increased weight and adiposity phenotypes,
we hypothesized that STAT would increase the incidence
and severity of metabolic diseases, including type 2 dia-
betes (T2DM) and NAFLD. To address this hypothesis,
we conducted several studies in STAT and control mice in
the weeks prior to sacrifice, including tests of glucose and
insulin tolerance. While there was no significant difference
in recovery of glucose levels in the STAT and control
mice, both groups had markedly impaired glucose toler-
ance and incomplete recovery (Fig. 3a, b); the obese mice
in this study were highly glucose intolerant, regardless of
STAT exposure.
In insulin tolerance tests, there was significant insulin
resistance in both STAT males and females compared to
controls (Fig. 3c, d), in the earliest time period after the
insulin provocation. Because many of the control ani-
mals experienced severe hypoglycemic shock and had to
be withdrawn from the test prior to 120 min, we lacked
sufficient power for assessment across the usual course
of the ITT. At the relatively high level of insulin used,
the STAT mice were less sensitive to hypoglycemia than
were the controls, due to their relative insulin insensitiv-
ity (resistance).
To further quantify the metabolic impact of STAT,
we calculated the HOMA-IR index [14]. By this index,
based on fasting glucose and insulin values, STAT was
found to significantly increase insulin resistance (Fig. 3e)
in both males and females. Alternatively, using a pre-
defined threshold for elevated HOMA-IR scores, STAT
males had a significantly higher incidence of elevated
HOMA-IR (Fig. 3f; p <0.05) compared to controls. Al-
though not statistically significant, only STAT females,
and not control females, had elevated HOMA-IR scores
(Fig. 3f ). These results, consistent with the ITT results,
point to substantial alterations in glucose regulation in
the STAT/HFD model.
STAT affects metabolic hormones and inflammatory
markers
Based on the altered glucose homeostasis observed in
STAT mice, we measured six other hormones and in-
flammatory markers involved in metabolism, which we
hypothesized would be differentially affected by the STAT
exposure. As expected from the IPGTT and IPITT, fasting
serum insulin (p <0.05; Fig. 3g) and C-peptide (p <0.001;
Fig. 3h) were significantly elevated in STAT males, al-
though not significantly affected in females. Concordant
with the increased adiposity, serum leptin was increased
in both STAT males and females (p <0.001 in both; Fig. 3i).
In contrast, serum ghrelin levels were significantly
lower in STAT males and females compared to con-
trol mice (p <0.05 in both; Fig. 3j). Since metabolic
and sex differences may be related to levels of the
pro-inflammatory cytokines-TNFα and IL-6, respect-
ively [42], we examined these in the context of the
experiment. Circulating IL-6 was significantly elevated
in females (p <0.05; Additional file 5: Figure S4A) but
not in males, and circulating TNFα (Additional file 5:
Figure S4B) was not significantly elevated in either
sex. These data reflect the enhanced obesity in mice
(See figure on previous page.)
Fig. 2 STAT enhances weight gain and adiposity. a Scale weight was measured 3–5 times each week beginning at week 4 (day 28) of life. Group
data were smoothed to the second order (3-neighbor method). p values were calculated using piecewise linear regression to assess rate of
growth. b, c Weight at week 4 (b) and sacrifice (week 32; c). p values reflect ANOVA with Bonferroni’s correction for multiple comparisons. A
high-fat diet (45 % kcal from fat) was introduced to all groups at week 13. DEXA was used at 4, 8, 12, 20, 24, and 28 weeks of life and values
are shown as Mean ± SD. d, e Lean mass in male and female mice. f, g Fat mass in male and female mice. Data in a, d, e, f, and g are reported
as mean ± SEM. p values calculated from individual mouse data (Mann–Whitney U test). In all panels: *p <0.05; ***p <0.001
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Fig. 3 (See legend on next page.)
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exposed to both STAT and HFD, and provide further
definition of the sex differences observed.
STAT affects hepatic steatosis
Upon sacrifice, fatty infiltrates in the liver were visible in
13 of 37 mice (Fig. 4a; 10/18 in STAT, 3/19 in control;
p = 0.017). Based on these observations, we performed
microscopic examination of the liver, grading histology
using the NAFLD Activity Score (NAS) [21] (Fig. 4b).
Scores for all STAT males were above the diagnostic
level for NAFLD with values significantly higher than
for controls (p <0.001) (Fig. 4c). Although hepatic in-
jury was not as advanced in STAT females, values were
significantly higher than in controls (p <0.01) (Fig. 4c).
Fibrosis (Fig. 4d), evaluated using the same scoring sys-
tem, was more severe and extensive in STAT than con-
trols (p <0.05) in both males and females. Significantly
more STAT mice had scores diagnostic for NAFLD
(score >5, with fibrosis) compared to controls (Fig. 4e;
p <0.001 males; p <0.01 females). These findings indi-
cate that the combination of STAT and HFD increased
the incidence and severity of NAFLD-like histologic
lesions compared to HFD alone.
STAT alters hepatic lipid storage and metabolism
Based on the hepatic histology at week 32, we quanti-
fied the hepatic lipid content. Total cholesterol was
increased in STAT mice to a greater extent than in
controls (p <0.05) (Fig. 4f ) in females, but not males.
In both sexes, STAT livers had nearly twice the triglycer-
ide concentration of controls (p <0.001 for each compari-
son) (Fig. 4g). Free fatty acids were elevated in STAT
compared to controls (p <0.05) (Fig. 4h) in males, but not
females, representing another instance of sex differences
in responses to STAT.
Next, we assessed expression of several genes relevant
to steatosis. Cd36 and Vldlr expression were increased
in STAT to a greater extent than in control (Additional
file 5: Figure S4C; p <0.05 in both), consistent with the
increased lipid infiltration of the liver. However, genes
involved in fatty acid metabolism, lipid droplet formation,
fatty acid oxidation, and related transcription factors did
not differ. When the data were analyzed by outcome
rather than treatment group, expression of the cholesterol
efflux regulator Abca1 was lower in mice that had more
insulin resistance (Additional file 5: Figure S4D; p <0.05).
Conversely, Cd36 was borderline elevated in mice that
had increased insulin resistance (Additional file 5: Figure
S4E; p = 0.055) and in those that had met criteria for
NAFLD (Additional file 5: Figure S4F; p = 0.055).
STAT effects on phylogenetic diversity of the intestinal
microbiota
To assess the relationship of the phenotypic changes to
gut microbial composition, we first addressed parameters
of community ecology, beginning with markers of com-
munity richness. Although α-diversity values were gener-
ally higher for the STAT mice compared to controls early
in the experiment, the only significant difference (p <0.05,
Mann–Whitney U test) was at week 8 (Fig. 5a).
Microbiota community structures are distinct between
groups
To assess the microbial community structure determined
by unweighted UniFrac analysis of the studied samples, we
visualized selected time points in relation to dietary transi-
tions by principal coordinates analysis (PCoA) (Fig. 5c).
The weeks shown represent the last sample before weaning
onto normal chow (week 4), prior to the transition from
normal chow to HFD (week 11), shortly after the transition
(week 16), and study end (week 30), respectively.
Three female mice received STAT but did not show
changes in any phenotypic changes specific to the STAT
exposure (see Fig. 2c; these mice were termed female
non-responders (FnR)). Based on UniFrac distances, at
week 4, community structure of two of the FnR mice
were STAT-like, while the third was control-like (p >0.05),
but by week 11, all three FnR communities were indistin-
guishable from those in other STAT-exposed female mice,
continuing through week 30 (p <0.05, compared with
controls at each week; data not shown). These findings
suggest that microbiota differences linked to differential
outcomes in the FnR mice may have occurred prior to
week 11.
When samples were grouped by treatment, the UniFrac
distances were significantly different between intra- and
inter-group measurements at each week (Additional file 6:
Figure S5; p <0.005 for all weeks), indicating that the
(See figure on previous page.)
Fig. 3 STAT disrupts glucose homeostasis, promoting insulin resistance. For glucose and insulin tolerance testing of 30-week-old male and female
mice, six mice from each group were challenged with 5 g/kg dextrose (IPGTT), or with 0.5 U/kg human insulin (IPITT) by intraperitoneal injection.
Blood glucose was measured by glucometer at 0, 15, 30, 60, and 120 min post-injection. p values reflect differences in rates of change comparing
STAT and control. a, b Glucose tolerance. c, d Insulin resistance. e HOMA-IR was computed as ((Glucose mg/dL) × (Insulin mU/L)/405), as described
[1] with values measured at fasting (time 0). p values determined by Kruskal–Wallis test (*p <0.05). f Observed mice with elevated HOMA-IR (>13.2).
p values calculated by Fisher’s exact test (*p <0.05). Serum was collected at 32 weeks for analysis by MILLIPLEX® MAP Magnetic Bead Panel. g Insulin,
h C-peptide, i leptin, and j ghrelin. Each point is the mean of duplicate tests. Data in a, b, c, and d are reported as mean ± SEM. p values determined
by Kruskal–Wallis test (in all panels: *p <0.05; **p <0.01; ***p <0.001)
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Fig. 4 STAT promotes NAFLD through hepatic lipid accumulation. a, b Ex vivo images and H&E stained slides (magnification × 40), showing the
scope of liver pathology. NAS score and fibrosis were determined by standardized histological scoring methods [2] with blinded readers averaging
the results of ten fields per mouse for each criterion tested. c NAS score by group. The dashed line denotes the diagnostic threshold (>5) for NAFLD.
d Fibrosis extent and severity scored from trichrome-stained sections. e Observed percent of mice with diagnostic NAFLD scores (>5; p value by
Fisher’s exact test). p values were calculated by Kruskal–Wallis test, unless noted. Lipids were extracted from frozen livers, quantified, and normalized
to protein. f Cholesterol, g triglycerides, and h free fatty acids. Data in c, d, f, g, and h are reported as mean ± SEM. p values were calculated by paired
t-test. In all panels: *p <0.05; **p <0.01; ***p <0.001
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community structures of the control and STAT groups
were distinct. When specimens were grouped by clinical
phenotype (NAFLD, insulin resistance) or by not showing
the pre-defined disease definitions (healthy), there were
distinct differences at weeks 4, 11, and 30 (Additional
file 6: Figure S5; p <0.005), but not at week 16. These
results provide evidence that before HFD initiation, the
intestinal microbial communities in mice that devel-
oped disease were distinct from those that did not. Al-
though the addition of HFD diminished this distinction,
the communities again were separate, long after the
transition (week 30).
Differentiating taxa
On the day of weaning (week 4), control mice were
enriched in Firmicutes and Candidatus Arthromitus
(“Savagella”) (SFB), while STAT mice were enriched in
Bifidobacterium, S24-7, and Prevotella, as determined by
LEfSe [24]. While some individual taxa differed, that pat-










































Fig. 5 STAT alters microbial communities. a α-diversity of all samples over time, rarefied to a depth of 1014. Only differences observed at week 8
were significant (p <0.05). b STAT exposure and diet corresponding to the PCoA at weeks 4, 11, 16, and 30. c–d PCoAs of beta diversity at weeks
4, 11, 16, and 30. c Control vs. STAT, d healthy vs. disease outcome. p values calculated by Kruskal–Wallis and AUC analysis (*p <0.05; **p <0.01;
***p <0.001). Adonis testing also indicated significant differences (p <0.0005) between the UniFrac distances for the diet:treatment and diet:disease
features, when accounting for the repeated measures design (Additional file 3: Table S1)
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chow (week 11). When the mice were receiving HFD
(week 16), the patterns continued similarly, except that
SFB and Prevotella differences disappeared, and Allobacu-
lum and Actinobacteria, enrichment was seen in control
and STAT mice, respectively (Fig. 6a).
In controls, the week 4 to 11 transition showed a shift
from Firmicutes-dominance, whereas the STAT transition
was accompanied by a bloom in Proteobacteria (Fig. 6b).
The transition between weeks 11 and 16 differed from the
earlier transition, with the selective power of HFD having
similar effects on control and STAT mice. The further
transitions between weeks 16 and 30 similarly affected
control and STAT communities (Fig. 6b). Thus, the effects
of HFD on individual taxa appear to overwhelm the con-
tinuing effects of STAT.
Based on the LEfSe results, we sought to determine if
any taxa could predict whether a host would develop meta-
bolic disease (defined as insulin resistance or NAFLD). To
accomplish this, a Random Forest classification model was
built to predict disease outcome (class) based on bacterial
OTU relative abundances (features) for each week of life.
Of particular interest was the observation that for early
weeks (prior to week 6); six OTUs were predictive (Prevo-
tella, Lactobacillus, Erysipelotrichaceae, SFB, and two
different S24-7 OTUs). The model had substantially (more
than twofold) better than random predictive power at
nearly all time points (Fig. 6c).
To understand the developmental differences in mi-
crobial communities, we calculated microbiota-by-age
z-scores (MAZ) [11, 25] to compare the communities
observed in control and STAT that did not develop
disease, with the STAT mice that did (Fig. 6d). Intestinal
microbiota follow reproducible patterns of community
succession during early life, allowing “microbiota age” to
be used as a benchmark of normal intestinal development,
as described in studies of humans [25]. In this model, a
maturity difference from control indicates either accel-




Fig. 6 Differential microbial features between STAT and control. a LEfSe cladograms showing discriminant taxa between control and STAT at
weeks 4, 11, 16, and 30, respectively, with corresponding diet. All identified taxa were significantly altered by Kruskal–Wallis test (p <0.05) and had
at least twofold increase by LDA. b Inter-week comparisons in control (upper) or STAT (lower). The week 4 to 11 comparison shows changes across
weaning, the week 11 to 16 comparison shows changes from the introduction of HFD, and the week 16 to 30 comparison shows changes with
increasing age. c A Random Forest classification model was built to predict disease outcome (class) based on bacterial OTU relative abundance
(features) for each week of life. Heat map indicates the importance of each OTU (as mean increase error %) to the disease prediction models at
each stage of life. The mean increase error for each OTU indicates the incremental decrease in prediction accuracy if that OTU is removed from
the model. Highlighted time points show HFD. The table lists the predictive accuracy of the model by week. d Average microbiota-by-age z-score
(MAZ) over time; z-score = 0 indicates appropriate maturation over time; higher or lower z-scores indicate accelerated or delayed microbiota
development, respectively. ***p <0.001 relative to Control, one-way ANOVA with Fisher’s LSD adjusted for false-discovery rate
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microbial community. At week 4, samples from the
STAT mice that would later develop insulin resistance
or NAFLD had significantly lower MAZ scores than
controls (p <0.001), but differences were lost at weeks
11, 16, and 30. These data provide evidence that STAT
can delay the normal development of the early-life
microbiome, and that this delay is associated with ele-
vated risk for metabolic diseases in later life.
Associations between host phenotypes and microbial
taxa
We applied multi-level, sparse PLS models to fecal micro-
biota data to assess linear relationships between OTUs
and seven host phenotypes (Fat, Lean, BMC, DMI,
Weight, Weight + 1, and NAFLD). We verified the efficacy
of a multi-level linear model by visualizing the within-
subject portion of the clr-transformed data. ISOMDS
indicates clear separation between subjects of differing
groups (Fig. 7a compared to Additional file 4: Figure S3A).
We also computed biplots for the sPLS model (Fig. 7b
and Additional file 7: Figure S6B), with sample scores
colored by (scaled and centered) response variable and
significant OTUs, represented by a loading vector colored
by phylum.
Overall, 29 taxa (about 4 % of the total) were selected
by the fully specified sPLS model, and three additional
a b
Fig. 7 Fecal microbial compositions are associated with host body phenotypes and disease indications. a Isometric multidimensional scaling (MDS) of
Euclidean distances between clr-transformed OTU compositions, with within-subject variances extracted. The first two MDS components are shown,
with Control vs. STAT and NC vs. HFD (point color, shape) explicitly modeled in this approach. This was done by evaluating between-subject variances
within each respective group and subtracting from the full dataset. b Within-subject response-selected OTUs are shown as biplots. For each phenotype
of interest (NAFLD, BMC, or Weight), the relevant two-component (out of seven possible latent components) subspaces from the sPLS model are
shown. Taxa are filtered for statistical significance (α = 10–2) and key taxa are highlighted for biological significance. “Response Level” indicates the
centered and scaled within-subject variances of the relevant measurement
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OTUs (two Clostridiaceae, and Odoribacter) were found
to not be significant at α = 10–2. However, we found a
large number of significant associations between taxa
and body composition phenotypes (Additional file 8:
Table S2). With the exception of two S24-7 families, all
other Bacteroidetes OTU abundance levels were positively
associated with body mass phenotypes, while Firmicutes
associations were mixed.
More specifically, we found that Lactobacillus (n = 2)
OTUs to be significantly associated with Lean, BMC,
DMI, and Weight and one other Lactobacillus directly
associated with Fat, DMI, Weight, and Weight + 1. This
is consistent with prior findings that Lactobacillus
reuteri reduces abdominal fat and age-associated weight
gain [43]. Turicibacter genera (n = 2) were found to be
negatively associated with DMI and Fat, but were not
significantly associated with other body composition
measurements, consistent with prior studies of low-dose
antibiotic exposure [12] and HFD feeding [44] in mice.
A single Anaeroplasma genus was negatively associated
with BMI, but not NAFLD, which is consistent with
HFD administration in C57BL/6 J mice [45] and abun-
dance enrichment in low-weight rabbits [46].
Notably, we found a negative association between an
Allobaculum OTU and NAFLD, accompanied by signifi-
cant positive associations to other body composition
measurements. Our findings are consistent with the
previous observations that Allobaculum has been dir-
ectly correlated with adiposity after switch to a HFD
[12], yet negatively correlated with the development of
the metabolic syndrome and total cholesterol levels
[47, 48]. Finally, we also find Candidatus Arthromitus
(SFB, n = 3 OTUs) to be negatively associated with body
composition phenotypes, primarily Weight, BMC and
Lean (consistent with elevated levels of SFB in control vs.
STAT mice reported in [12]) with one particular SFB
OTU predicted to have additional associations with
NAFLD, Fat, and Weight + 1.
Microbial network topology corresponds to host
physiology
We next sought to develop a network model that would
permit insights about microbial relationships with the
physiology of the hosts studied. The PLS model that we
used transforms the primary microbiota population data
into a subspace that maximally co-varies with the host
responses. Using a Gaussian mixture model with boot-
strap stability validation of cluster assignment, we per-
formed unsupervised clustering of these transformed
data. These studies revealed that samples are best grouped
into six clusters, each of which has a distinct phenotype
profile (Fig. 8a). Clusters 1, 3, and 5 were primarily associ-
ated with STAT mice. The switch from normal chow to
high fat diet largely corresponds to the transition from
Cluster 3 to Cluster 5. Clusters 2 and 4 were associated
with Control mice receiving normal chow or HFD, re-
spectively. As such, Cluster 4 comprises the microbiota in
fecal samples primarily from 18–30-week-old mice.
To identify whether changes in host physiology are
also reflected in the global rewiring of the gut microbial
community structure that we observed, next we inferred
microbial association networks from each of the six
sample groups and analyzed their global topological
network properties. Using graphlet correlation distance
as a global distance measure between networks, and
using isometric MDS as an analytic tool, we inferred a
low-dimensional embedding of the microbial association
networks (Fig. 8b). Importantly, these largely recapitulate
the transitions seen in the subspace clustering described
above (Fig. 8a). Networks 2 and 3 are closest to network
1. Networks 3 and 5, representing the gut microbiome
community in samples from mice that received STAT
are distinct from networks 2 and 4, which represent the
microbial communities in samples from control mice
Network 6, which is inferred from samples of older
mice, is distinct from all the other networks.
Since clusters are dominated by samples that were
obtained from mice under specific experimental pertur-
bations, we classified the networks as being dominated
by STAT (clusters 1, 2, and 3) or Control (2 and 4) or by
normal chow (NC) (clusters 1, 2, and 3) or by HFD (4, 5,
and 6). Then we calculated several graph topology sta-
tistics to assess trends as a function of sample type
(Additional file 9: Figure S7). Overall, NC and STAT
networks comprise more taxa, have larger network di-
ameters, and show lower average betweenness and de-
gree centrality. These are ecological terms indicating a
node’s centrality in a network and the number of cross-
ties, and low values are consistent with greater dispersion
within the network. The HFD and Control networks
tended to be more modular. Finally, the NC and Control
networks had higher assortativity at the phylum level; this
means that under normal conditions in the absence of
antibiotics or an abnormal diet, particular OTUs are more
likely to be directly associated with common phyla than
under antibiotic and HFD exposure.
We also analyzed OTUs that could potentially serve
as keystone species in the different association net-
works. For each network, we identified the top two taxa
that serve both as hub species (having high node
degree) and as bottleneck species (as characterized by
the highest betweenness centrality) (Additional file 10:
Figure S8). Across all networks, these potential key-
stone taxa are largely represented by Lactobacillus, Lach-
nospiraceae, and S24-7 families. For instance, in network
1, the top two taxa are Eubacterium dolichum and Lacto-
bacillus reuteri. While these OTUs are not predicted to be
directly associated with host physiological changes, both
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species are known to have strains that are resistant to
penicillin [49, 50] and require sugar and amino acid
import for survival in the host GI tract. In particular,
L. reuteri has been shown to be a key mediator in
host and microbe interactions for processing carbohy-
drate metabolites [51].
In addition to changes in microbial compositions,
we also analyzed whether overall network robustness
correlates with host health, since microbial ecological
networks should have evolved to be resilient to distur-
bances. One example of this concept would be redun-
dancy in network wiring that may ensure access to a vital
metabolite. Thus, we hypothesized that Western-style in-
terventions would promote network fragility by disrupting
a critical threshold of keystone taxa or by changing the




Fig. 8 Network properties recapitulate physiology. a For each of the six clusters, which were defined from clustering scores in the multilevel
sPLS model-fitted subspace, we show the treatment group identity (STAT/Control and NC/HFD, colored horizontal bars) and average physiological
responses (vertical bar plots). Since each response is scaled and centered, the axes represent the mean response over the whole population at each
time point. The state-change diagrams represent real-time transitions for the community in an individual mouse moving into a new cluster. For greater
clarity, we removed transitions representing fewer than six mouse cluster changes. Clusters 1 and 3 are predominantly obtained from communities in
STAT mice early-in-life, and Cluster 2 represents the early-in-life communities in control mice. The switch from NC to HFD corresponds to transitions
from Cluster 3 to 5 and from Cluster 2 to 4. Transitions to Cluster 6 primarily include samples from week 30 STAT mice and week 18 and 30 Control
mice. The circular arrows shown indicate those communities in mice that do not change clusters b We inferred networks using SPIEC-EASI [34] over
the set of samples defined by each cluster. To compare graphs, we include a two-dimensional embedding of graphlet correlation distances (using
isometric MDS, with the network positions shown as colored hexagons). These show that based on summarized local network topologies, closeness
networks reflect cluster identity. The networks are shown in force directed layouts (overlaid on the ISOMDS, near their respective position in the
embedding) and nodes are colored at the Phylum level, except for the two nodes with the highest betweenness (shown in gray, see also Additional
file 6: Figure S6). c We used natural connectivity to assess the robustness of microbial ecological interaction networks to sequential node removals. The
order of node removals was either random or ordered by degree or betweenness centrality. Natural connectivity is shown as a function of the relative
size of the network
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To test this hypothesis, we used natural connectivity
as a general stability metric of the inferred networks
after simulated network “attacks”. We found that only
the network from cluster 2 – control mice receiving
normal chow – was reliably robust, independent of the
specific node removal strategy (Fig. 8c). Network 4,
representing the microbial community after the switch
to HFD, showed a decrease in network robustness, yet
remained more stable than most STAT networks. Inter-
estingly, the natural connectivity of network 4 decreased
at a slower rate when bottleneck taxa were removed
compared to hub taxa. This property suggests an in-
creased redundancy of bottleneck taxa in the absence of
antibiotic exposure. Importantly, microbial networks
inferred in the communities in the STAT-exposed mice
were found to be particularly fragile under targeted at-
tacks, independent of the diet.
Discussion
This study both confirms and extends our prior stud-
ies of antibiotic-induced growth promotion in murine
models [11–13]. We confirm the growth promotion
of STAT [12, 13] and its enhanced effect in combination
with HFD compared with HFD-only controls [12]. Con-
sistent with the enhanced adiposity were elevated plasma
levels of insulin, C-peptide, leptin, and triglycerides [52].
The decreased ghrelin observed might also reflect the
extreme adiposity of the mice [53]. Our observation that
the perturbed microbiome is a key player in the develop-
ment of NAFLD is consistent with a large body of work in
both rodent models and human studies [6–10].
This work included both males and females; while the
sexes shared many of the same STAT-induced phenotypes,
there are several key differences in specific phenotypes
related to diabetes, hyperlipidemia, and inflammatory
cytokines. This model, and its manipulation, provides
approaches to untangling the complex sex-specific patho-
physiology observed in many prior studies [54, 55]. We do
not have simple answers for the differences observed
between male and female mice; however, we found differ-
ences in our prior study as well [12]. There are many prior
citations in the literature showing sexual dimorphism in
relation to diet and adiposity [56]. Adiposity and lean
mass are primary determinants of glucose responsiveness;
differences in body composition generally underlie these
observations [57]. Hormonal differences between males
and females may play a role in explaining these observa-
tions; and recent microbiota transfers between male and
female mice affected phenotypes in a murine model of
type 1 diabetes [58].
Cox et al. showed that early-life antibiotic exposure
was of critical importance to the development of the
obesity phenotype [12]. This study provides further
supporting evidence. As previously observed [12], both
body weight (Fig. 2b) and microbial community compos-
ition (Fig. 5) were already altered by the first measure-
ment at the time of weaning (4 weeks). Furthermore, by
the time of this earliest measurement, we found evi-
dence for microbial community immaturity (Fig. 6c, d),
taxa predictive of disease (Figs. 6c and 7, Additional file
8: Table S2), and altered community composition in
mice that would eventually develop disease (Fig. 6c). To-
gether, these studies further emphasize the criticality of
early life microbiome perturbations in the development
of later in life phenotypes, especially as enhanced by
further environmental (antibiotic and/or dietary) insults.
Our prior studies addressed whether a relatively brief
exposure (first 4 weeks of life) was sufficient for an
adiposity phenotype; we found that it was [12]. In that
study, we also compared starting antibiotics slightly pre-
birth and post-weaning; although the effects were in the
same direction, the stronger phenotype was in the mice
with the earlier exposure.
We had previously observed that female STAT mice
consumed significantly more food than female control
mice. In the current study (Additional file 1: Figure S1),
female STAT mice consumed significantly fewer calories.
Microbiome differences in the Cox et al. study (LEfSe
comparison of STAT vs. control at 4 weeks) also seem
inconsistent with the current study. There were a num-
ber of differences between the present studies and our
previous observations, including the age at which the
animals were studied in metabolic cages, and even the
form of penicillin used. As such, it is hard to reach con-
clusions across experiments and we focus on differences
within experiments in the different experimental groups.
STAT enhanced the abnormalities in insulin homeo-
stasis observed in the mature mice, often already obese,
that were receiving long-term HFD. Both male and fe-
male mice had multiple abnormal markers consistent
with T2DM. Two recent, large epidemiologic studies in
England and Denmark, point to prior exposure to antibi-
otics, even years earlier, as a risk factor for development
of T2DM [59, 60]. The current studies provide a model
system to more closely examine the pathogenic relation-
ship between early life microbiome perturbation and
later development of obesity and related metabolic
dysfunction.
In the presence of HFD, STAT exposure causes marked
hepatic abnormalities. By 32 weeks, the increased hepatic
fat was visible to the unaided eye (Fig. 4a), while micro-
scopic examination revealed marked increases in hepatic
steatosis and hepatocyte ballooning (Fig. 4b, c). The fat
accumulation was primarily triglycerides (Fig. 4g), with
increased Vldlr expression in STAT (Additional file 5:
Figure S4C) and diminished ABCA1 in mice with insulin
resistance (Additional file 5: Figure S4D). These findings
suggest that STAT-exposed mice accumulate hepatic
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lipids by both increased uptake (via VLDL receptor) and
decreased efflux through ABCA1. One possible explan-
ation for this phenomenon is altered gut permeability
[61], allowing translocation of bacteria, their constituents,
and/or their products to the hepatic parenchyma via the
portal circulation; we plan to explore this hypothesis in
future studies.
Since normal chow is high in plant fiber, cellulose-
degrading members of the phylum Firmicutes dominate
the microbial communities of control mice. As seen in
this and other studies [12, 13], STAT exposure reduces
Firmicutes dominance, with members of other phyla
increasing in relative abundance. Obesity in humans and
rodents has been associated with decreased phylogenetic
diversity of the intestinal microbiota [62, 63]; however,
these observations generally concerned humans and mice
that already were obese. The current findings are consist-
ent with our previous observations in STAT-exposed mice
that increases in measured diversity was a predictor of
the development of obesity [12]. Consistent with prior
studies [12], analysis of fecal β-diversity shows that
STAT-exposed communities are distinct from control
from the first observation at 4 weeks, throughout life,
and across all dietary interventions (Fig. 5c). LEfSe
analysis showed parallel dynamic patterns in the abun-
dance of specific taxa, in both STAT and control com-
munities at each time point. Importantly we found that
when the 4-week-old mice were grouped by outcome
and not by treatment, the communities from those that
would eventually develop NAFLD or insulin resistance
were distinct from the communities of those who would
remain healthy. One implication of this finding is that
community structure in early life could be used for both
prediction and for possible interventions to prevent devel-
opment of metabolic diseases.
Detecting significant host-taxa associations from high-
dimensional microbial compositional data, under a multi-
level experimental design and with multiple, relevant
clinical indications is an important challenge in micro-
biome research. Here, we developed a general analysis
framework based on compositionally robust data trans-
formations, data decomposition steps, and a sPLS re-
gression that accounts for compositional biases and
treatment-irrelevant variation in the data. This has led
to predictions about the relationship between specific
OTUs and host phenotypes, while correcting for pos-
sible colinearity within OTU and response measure-
ments. Many of the inferred direct relationships and
targeted predictions in this study are consistent with
previous studies of relative abundance changes in mam-
malian guts.
We were also able to make novel specific predictions,
e.g. that Allobaculum may increase in abundance in
direct association with weight gain during aging, but still
be largely protective against NAFLD, particularly in the
absence of STAT. Describing gut microbiota compos-
ition in mice prone or resistant to NAFLD development,
Le Roy et al. observed a negative association between
Allobaculum and NAFLD, consistent with our findings
[7]. The strong hepatic phenotypes were not apparent
until sacrifice, so we did not have the opportunity to
explore them pre-mortem. However, we found high
NAFLD activity scores (Fig. 4c) and substantial inflam-
mation (Fig. 4d), and were able to characterize the
nature of the lipid accumulation (Fig. 4f–h). Future
studies will focus on specific steps leading to these
extreme phenotypes.
We had previously observed significant differences in
bone mineral density due to STAT exposures [12, 13].
To address this point further, we sought to determine
whether microbiota composition would predict scale
weight at the next measured time point. Although using
the PLS model, there are differences between Weight
and Weight + 1, we did not quantify these relatively
minor effects. On the other hand, including Weight + 1
led to a stable clustering solution; therefore, we kept
this response variable for consistency while developing
the pipeline.
The proposed analysis techniques also have the power
to correct for transitive correlations, e.g. by distinguish-
ing between direct and indirect associations between
specific SFB OTUs and NAFLD or other body compos-
ition measurements. Additionally, we have demonstrated
that learning OTU-OTU associations in different eco-
logical contexts can lead to predictions about how entire
ecosystems are structured and to identification of key-
stone species. While these species may be distinct from
those that demonstrably co-vary with host phenotypes,
they could be critical control points through which
ecological interventions propagate. For instance, we have
found that non-intervention corresponds to overall
network stability, even in an inbred mouse strain, but
targeted removal of critical nodes in the presence of low
doses of antibiotics could lead to ecosystem collapse.
These putative keystone taxa: E. dolichum and, in par-
ticular L. reuteri, have been shown to have probiotic
effects and many microbe interactions. We confirm this
finding with network analysis and additionally postulate
that these taxa could be the last line of defense in the
presence of a significant intervention (STAT). However,
before targeted experiments can be done, we must
identify species and strain level identities for these taxa,
as well as construct dynamic models, which requires
more densely sampled time series. The first point guar-
antees specificity of a transfer or targeted intervention,
while the second point would allow us to generate
hypotheses about the direction and magnitude of the
impact.
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Conclusions
In conclusion, extension of the STAT studies provides
new models relevant to the pathogenesis of obesity, T2D,
and NAFLD. The consistency of the observations, both
internally and in relation to prior studies [12, 13], indicate
the tractability of the model for future investigations. Use
of perturbations, such as dietary and antibiotic exposures,
and developing new computational tools provides new
approaches for assessing the complexity inherent in
studies of the relationship between the gut microbiota and
metabolic phenotypes and disease.
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Additional files
Additional file 1: Figure S1. STAT did not change energy balance, or
bone morphometrics. STAT (3 male, 3 female) and control (3 male, 3
female) mice were housed individually in metabolic cages for 5 days.
A Gross caloric intake. Food consumed was measured daily by weight.
Calories per gram from the chow package insert were used to calculate
calories consumed. Each point represents a single 24 h of data. B Gross
fecal calories. All fecal pellets were harvested for each mouse each day,
and homogenized to create a daily fecal pellet for each mouse. Total dry
fecal volume per day combined with bomb calorimeter values for the
daily pellets were used to determine total calories out. C Net daily
calories, calculated as (calories in (from A) – calories out (from B)).
D Proportion of daily caloric intake retained (Net daily calories (from C)
divided by gross caloric intake (from A)). Data points are the mean of
duplicate determinations (Kruskal–Wallis test; *p <0.05). DEXA bone
measurements for all four groups: E mineral density, F mineral content,
and G area. Arrow indicates start of the HFD. p values calculated from
individual mouse data (Mann–Whitney U test; *p <0.05; **p <0.01;
***p <0.001). Gray dots signify outliers greater than 2 standard
deviations from the mean. (PDF 1337 kb)
Additional file 2: Figure S2. Quality scores across all sequenced bases.
Amplicon pools were sequenced on the 2 × 150 bp Illumina MiSeq
platform and total reads were across both paired ends. A For 10, 725,612
total reads, 3,688,882 were joined using the EA-utils toolbox. To ensure
higher fidelity of paired-end read-joining, bases with PHRED threshold
<18 were trimmed from the ends of each sequence read (number of
“Trimmed Seqs” for each paired end read). B, C With summarization
produced by FastQC, the average and range of base-pair quality was
high (PHRED scores >30) across the length of the sequenced reads.
(PDF 89 kb)
Additional file 3: Table S1. Adonis tests of repeated measures.
(DOCX 20 kb)
Additional file 4: Figure S3. A We used the mclust package to find the
optimal model and number of mixture parameters (number of data
classes) using a 14 variants of a Gaussian mixture model (GMM), over 3-9
possible data classes. The VVE model (ellipsoidal, equal orientation) under
6 latent components was selected, under a Bayesian Information
Criterion (starred). The EVE model (ellipsoidal, equal volume and
orientation) was also competitive, but slightly suboptimal. For a full list of
possible models, see the help page for ’mclustModelNames’ in R. B To
visualize the clustering solution, we back-transformed the data (sPLS
scores) using the within-cluster precision matrix and scaling factor,
estimated by the GMM independently for each cluster. The first three
model components are shown, together with cluster identity and
Control/STAT status. (PDF 65 kb)
Additional file 5: Figure S4. Inflammatory and metabolic profiling
in control and STAT mice. Serum was collected at 32 weeks for analysis
by MILLIPLEX® MAP Magnetic Bead Panel. Circulating inflammatory
hormones A IL-6 and B TNF-α were measured. Mice were sacrificed
at 32 weeks of age and hepatic gene expression was assessed using
RT-qPCR. C Genes involved in free fatty acid (FFA) transport, triglyceride
(TG) uptake, fatty acid catabolism, TG synthesis, lipid droplet formation,
transcription factors, and FFA oxidation were measured. D Abca1
expression from mice that had normal vs. high HOMA-IR scores. E Cd36
expression from mice that had normal vs. high HOMA-IR scores. F Cd36
expression from mice that had normal vs. positive NAFLD diagnosis.
p values calculated from individual mouse data (Mann–Whitney U test;
*p <0.05). (PDF 64 kb)
Additional file 6: Figure S5. STAT alters microbial communities. Unifrac
distance at weeks 4, 11, 16, and 3. A Control (C) vs. STAT (S); “I” represents
intergroup measures. B Healthy (I) vs. disease (D) outcome; “I” represents
intergroup measures. C Control (C) vs. STAT (S) with non-responder
females; “CN” represents the intergroup measure between control
and non-responders; “NS” represents the intergroup distance between
non-responders and STAT. p values calculated by Kruskal–Wallis and
AUC analysis (*p <0.05; **p <0.01; ***p <0.001). (PDF 58 kb)
Additional file 7: Figure S6. Additional OTU-host phenotype associations.
A Isometric Multidimensional scaling (MDS) of Euclidean distance between
CLR transformed OTU compositions. The first two MDS components are
shown, with Controls vs. STAT and NC vs. HFD (point color, shape) leads to
an effective unsupervised grouping. B Additional biplots for within-subject
response-selected OTUs are shown. For each phenotype of interest (DMI, Fat,
Lean, Weight + 1), the relevant two component subspace from the sPLS
model (out of six possible latent components) are shown. Taxa are filtered for
statistical significance (α = 10–2) and key taxa are highlighted for biological
significance. “Response Level” indicates the centered and scaled within-
subject variances of the relevant measurement. (PDF 125 kb)
Additional file 8: Table S2. Significant Taxa-host associations as
determined from sparse PLS regression. p values are based on bootstrap
evaluation of the PLS permutation test compared to a permutation-based
null model on the variable support selected by sparse PLS. (PDF 43 kb)
Additional file 9: Figure S7. Since clusters are dominated by samples
under specific experimental perturbations, we classified networks as
being dominated by STAT (clusters 1, 2 and 3) or Control (2 and 4) or by
NC (clusters 1, 2 and 3) or HFD (4, 5, and 6). We computed a number of
graph topology statistics to assess trends as a function of sample type.
(PDF 70 kb)
Additional file 10: Figure S8. Betweenness centrality vs. Degree.
For each node, we computed the degree and betweenness
centrality. The top two OTUs by betweenness are consistent with
degree, and are highlighted in gray. For each network the lineages
of these are: 1. f__Erysipelotrichaceae;g__[Eubacterium];s__dolichum
and f__Lactobacillaceae;g__Lactobacillus;s__reuteri; 2. o__Clostridiales
and o__Clostridiales;f__Ruminococcaceae;g__Oscillospira;
3. o__Bacteroidales;f__S24-7 and o__Clostridiales;f__Lachnospiraceae;
4. o__Bacteroidales;f__S24-7 and o__Clostridiales;f__Dehalobacteriaceae;
g__Dehalobacterium; 5. o__Clostridiales;f__Lachnospiraceae;g__Roseburia
and o__Clostridiales; 6. o__Bacteroidales;f__S24-7 and f__Lactobacillaceae;
g__Lactobacillus. (PDF 301 kb)
Abbreviations
clr: Centered log-ratio; DEXA: Dual energy X-ray absorptiometry; FnR: Female
non-responders; HFD: High-fat diet; HOMA-IR: Homeostatic model
assessment of insulin resistance; IPGTT: Intraperitoneal (IP) glucose tolerance
tests; IPITT: Intraperitoneal insulin tolerance tests; ISOMDS: Isometric
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multidimensional scaling; LEfSe: Linear discriminant analysis effect size;
MDS: Multidimensional scaling; NAFLD: Non-alcoholic fatty liver disease;
pam: Partitioning around mediods; PCoA: Principal coordinates analysis;
SPIEC-EASI: Sparse Inverse Covariance estimation for Ecological ASsociation
Inference; sPLS: L1-penalized partial least squares regression; StARS: Stability
approach to regularization selection; STAT: Sub-therapeutic antibiotic
treatment; T2DM: Type 2 diabetes.
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